Conference call scheduled for 4:30 p.m. EDT today Exclusive distribution agreement signed with Shanghai Medtronic Zhikang Medical Devices Co. Ltd. for.
Conference call scheduled for 4:30 p.m. EDT today Exclusive distribution agreement signed with Shanghai Medtronic Zhikang Medical Devices Co. Ltd. for.
IceCure Medical Reports Financial Results for the First Half of 2022 and Recent Operational Highlights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the.
IceCure (Shanghai) MedTech, a wholly-owned subsidiary of IceCure Medical (ICCM), has signed a distribution deal with Shanghai Medtronic Zhikang Medical Devices, an affiliate of.